DUBLIN – (COMMERCIAL THREAD)–The “Pharmaceutical and Healthcare Industry in the United States – Forecast and Analysis 2021” report was added to ResearchAndMarkets.com offer.
With COVID-19 having severely impacted various industries in the United States, it is difficult to accurately predict how the pharmaceutical and healthcare market will perform in a short period of time. However, there is no doubt that the pharmaceutical and healthcare sector has been severely affected. With the economic slowdown setting in due to the pandemic, the U.S. pharmaceutical and healthcare industry is expected to slow in the near term.
The US pharmaceutical industry is a highly globalized industry dominated by multinational corporations with significant commercial activity in many countries and whose products are distributed and marketed around the world. In recent decades, the industry has undergone dramatic structural changes, with the boom in the biotechnology sector, substantial growth in demand driven by demographics and the substitution of other therapeutic modalities such as surgery, and increased competition from globally active generic manufacturers.
The report covers the following data:
In-depth coverage of the pharmaceutical and healthcare industry in the United States by sectors as well as an analysis of how the COVID-19 pandemic is affecting the industry.
We analyze the Prescription Drugs, Generic Drugs, Over the Counter Drugs segments and also analyze the clinical trials landscape in the United States.
A SWOT analysis of the pharmaceutical and healthcare industry in the United States.
A strategic analysis of Porter’s five forces on the U.S. healthcare and pharmaceutical industry is included and examines the bargaining power of buyers and suppliers, competitive rivalry in the industry, and the threat of new entrants and substitution in the industry. ‘industry.
We take a close look at the regulatory framework governing the pharmaceutical and healthcare industry in the United States.
Competition in the industry, as well as an in-depth analysis of major players like AstraZeneca, Eli Lilly, Glaxo Smith Kline and many more are included.
Main topics covered:
A. Executive summary
B. Definition of industry
C. Pharmaceutical and healthcare industry in the United States
C.1 Impact of COVID-19 on the industry
C.2 Analysis of the pharmaceutical sector
C.3 Health sector analysis
C.4 Prescription drug market
C.5 Patented medicine market
C.6 Market for over-the-counter drugs
C.7 Generic drug market
C.8 Clinical trials in the United States
D. Pharmaceutical and healthcare industry in the United States: SWOT analysis
D.1 Forces on which to build
D.2 Weaknesses to overcome
D.3 Opportunities to be exploited
D.4 Threats to be overcome
E. The American Pharmaceutical Industry: Analysis of Porter’s Five Forces Strategy
E.1 Bargaining power of buyers
E.2 Bargaining power of suppliers
E.3 Competitive Rivalry in Industry
E.4 Threat of new entrants
E.5 Threat of substitutes
F. Chronic medical conditions in the United States
F.2 Alzheimer’s disease
F.5 Cardiovascular disease
G. Industry regulatory framework
G.2 New Drug Regulations
G.3 U.S. Health Care Law
G.4 Other regulations
G.4.1 Prescription Drug User Fees Act
G.4.2 Regulations governing generic drugs
G.4.3 Bolar Amendment
G.4.4 Regulations governing biosimilars
G.4.5 Regulations Governing Over-the-Counter Drugs
G.4.6 Tax reform project
G.4.7 Pricing and reimbursement regime
G.4.8 Proposition 61 – The California Drug Price Relief Act
G.4.9 Senate Bill 17
G.4.10 Regulations governing the promotion of pharmaceutical products
G.4.11 What does the landscape of payers look like?
G.5 Challenges with intellectual property rights
H. Import / Export of pharmaceutical products
I. Competition in industry
I.1 Competitive landscape
I.2 Impact of COVID-19 on competition
I.3 Impacts on competition
I.4 Competition in the generic drug sector
I.5 Competition in the US pharmaceutical sector
I.6 Competition in the US drug distribution market
J. Forecast: Pharmaceutical and healthcare industry in the United States
J.1 Prospects for the US pharmaceutical industry
J.2 US Healthcare Industry Outlook
J.3 Outlook for the prescription drug sector
J.4 Patented Medicines Market Outlook
J.5 OTC Drug Market Outlook
J.6 Generic Drugs Market Outlook
K. Pharmaceutical and health industry: major players
Bristol Myers Squibb
Eli Lilly and company
Johnson & johnson
Merck & Co.
Teva Pharmaceutical Industries Ltd.
For more information on this report, visit https://www.researchandmarkets.com/r/1qhj68